Literature DB >> 24580774

Meta-analysis of the effect of percutaneous coronary intervention on chronic total coronary occlusions.

Ruogu Li, Shuansuo Yang1, Lei Tang, Yiqing Yang, Hui Chen, Shaofeng Guan, Wenzheng Han, Hua Liu, Jinjie Dai, Qian Gan, Weiyi Fang, Xinkai Qu.   

Abstract

BACKGROUND AND
PURPOSE: Coronary chronic total occlusion (CTO) is the last stage of coronary artery atherosclerosis. Percutaneous coronary intervention (PCI) is a therapeutic procedure used to recanalize vessels with total occlusion. However, successful recanalization of CTO is still not optimal, and the key influence factors are still uncertainty. Therefore, a scientific evaluation on the effective of PCI for CTO treatment is necessary.
METHODS: Relevant studies of PCI treatment for CTO were examined. Data were extracted and assessed by two independent clinical experts. Embase, PubMed and Medline et al. were used as database. The main research key words include "CTO", "PCI", "Stent", "Reopen", "long-term", "follow-up" and "outcome". Quality assessment was carried out according to the Cochrane Handbook. The selected data were pooled and analyzed using fixed-effect model and random-effect model. Heterogeneity was assessed using the I(2) test, Q test, L'abbe and Galbraith. Comprehensive Meta -Analysis 2.0 and Metanalysis 1.0 were used for statistics analysis in this research.
RESULTS: A total of 16 articles involving 6695 cases in successful CTO recanalization (CTO success group) and 2370 cases in failed CTO recanalization(CTO failure group) were included in this research. Low CTO success was associated with elder age, previous coronary artery bypass graft surgery (CABG) history, multi-vessel diseases and right coronary artery disease lesion. Six follow-up variables including major adverse cardiac events (MACE), recurrent myocardial infarction (MI), all-cause death, incidence of angina, subsequent CABG and cumulative survival rate were found significantly reduced associated with CTO success.
CONCLUSIONS: Clinical baseline characteristics such as age, previous CABG history and lesion baseline characteristics such as lesion length, multi-vessel diseases might be important factors influencing the successful rate of CTO recanalization. Compared to CTO failure patients, all six follow-up variables showed advantage for CTO success patients.

Entities:  

Mesh:

Year:  2014        PMID: 24580774      PMCID: PMC3974033          DOI: 10.1186/1749-8090-9-41

Source DB:  PubMed          Journal:  J Cardiothorac Surg        ISSN: 1749-8090            Impact factor:   1.637


Background

Coronary chronic total occlusion (CTO) is the last stage of coronary artery atherosclerosis, accounting for one third of the disease confirmed by coronary angiography [1]. CTO exists in about 50% of patients with coronary artery disease, which is often accompanied by complex lesions, in about 15% patients as reported, revealed by coronary angiography [2]. This disease can result in myocardium ischemia, myocardiolysis, reduction of the number of myocardial cells, ventricular remodeling which lead to decreased myocardium contractile, reduction of quality of life and poor prognosis [3]. Medication alone for CTO treatment does reduce the clinical symptom, but it has little effect on the long-term heart function and the improvement of the patients’ survival rate. Percutaneous coronary intervention (PCI) is a therapeutic procedure not only used to recanalize vessels with total occlusion [4], but also widely used in other aspects such as increase blood flow reperfusion, improve myocardial contractile and pump function [5], inhibit left ventricular remodeling and decrease adverse cardiac events [6]. However, PCI is considered not suitable for CTO lesions because of the lack in strong backup support by the guiding catheters or the difficulty in taking the contralateral coronary angiograms [7]. The success rate of CTO patients by PCI procedure is lower than that in non-CTO patients [8]. Revascularization for CTO lesions [9] is more difficult and influenced by baseline clinical characteristics, lesions level, intervention equipments and the manipulation techniques [10]. With the development of interventional technologies and physician’s manipulation techniques, the successful rate of PCI procedure on CTO lesions is significantly increased [8]. However, CTO recanalization is still accepted as an extremely challenging procedure in cardiovascular PCI treatments. The success of the recanalization for CTO in coronary interventions is vital [11]. However, the long-term outcomes such as cumulative survival rate, major adverse cardiac events (MACE), incidence of restenosis and reocclusion are still under debate based on different procedures and techniques [12]. Therefore, it is critical to scientifically evaluate the effectiveness and influential factors for CTO interventional treatment. In this study, publications on PCI procedure in CTO patients were systematically reviewed [13] and suggested potential influential factors that influenced successful rate and outcomes for PCI procedure [14].

Methods

Selection criteria for articles

Two investigators independently searched Embase, PubMed, Medline, Ovid, CCTR, CNKI, CMBdisc, and with additional manual search for related meeting abstracts and websites including American Heart Association American College of Cardiology, European Society of Cardiology, and national postgraduate thesis pool (from January 1990 to December 2009). The main research key words include “CTO”, “PCI”, “Stent”, “Reopen”, “long-term”, “follow-up” and “outcome”. No language restrictions were used. The inclusion criteria for selected studies comprised: 1) patients with CTO diseases, 2) comparisons of recanalization after PCI and unsuccessful recanalization and 3) the follow-up period of articles were at least one year. Studies with incomplete data or cases number less than 50 were excluded from the analysis.

Data extraction

Clinical results with prespecified data forms were selected by two independent investigators. Meta-analysis was conducted by two independent clinical experts and the data was pooled by fixed-effect model and random-effect model [15].

Quality assessment

Two independent investigators assessed the quality of eligible articles according to the Cochrane Handbook [16] with established methods. It includes 5 items: (i) Sequence generation; (ii) Allocation sequence concealment; (iii) Blinding of participants, personnel and outcome assessors; (iv) Incomplete outcome data; (v) Selective outcome reporting.

Statistics analysis

The 95% confidence interval (CI) were calculated from abstracted dichotomous data of each study and pooled according to fixed-effects (inverse-variance weighted) and random-effects (DerSimonian and Laird) models. Statistical heterogeneity was assessed with Cochran’s Q via a chi-square test and quantified with the I2 test, P < 0.10 and I2 > 50% suggesting significant heterogeneity, I2 ≤ 25% considering low heterogeneity. Searching Software for analysis were Comprehensive Meta-Analysis 2.0 and Metanalysis 1.0.

Results

A total of 16 reports [17-32] during 1990 and 2009 (randomized controlled trials and retrospective studies etc.) were included in consistency with the selection criteria. Totally 6695 cases in successful CTO recanalization (CTO success group) and 2370 cases in failed CTO recanalization (CTO failure group) were included in this study.

Influential factors for CTO recanalization

In order to compare clinical and lesion baseline characteristics between CTO success group and CTO failure group, meta-analysis was performed on the studies of CTO revasculization with mean successful rate of 73.9% for CTO recanalization. Eight clinical baseline characteristics (including age, gender, hypertension, hyperlipidemia, diabetes mellitus, smoker, previous myocardial infarction history, previous coronary artery bypass graft surgery (CABG) history) and six lesion baseline characteristics (lesion length, left ventricular ejection fraction, multi-vessel coronary disease, left anterior descending artery lesion, circumflex artery lesion, right coronary artery disease lesion) were analyzed to assess discrepancies between two treatment groups. Among these, weighted average age difference between two groups was 0.083 (95% CI, 0.132 ~ 0.034, P = 0.001, heterogeneity, Q = 31.571, P = 0.005, I2 = 50.655%) (Figure  1), weighted average lesion length difference was -0.782 (95% CI, -1.499 to -0.065, P = 0.033, Q = 39.806 P < 0.001, I2 = 94.976%, Figure  2). The low CTO success rate was associated with previous CABG history (OR 0.707, 95% CI, 0.578 to 0.865, P = 0.001, Q = 1.962 P = 0.854, I2 = 0.00%, Figure  3) and multi-vessel diseases (OR, 0.649, 95% CI, 0.554 to 0.761, P < 0.001, Q = 26.943 P = 0.029, I2 = 44.326%, Figure  4). The other factors including gender, hypertension, hyperlipidemia, diabetes mellitus, smoker, previous myocardial infarction history, left ventricular ejection fraction, left anterior descending artery lesion and circumflex artery lesion did not affect the recanalization rate of PCI on CTO (P > 0.05).
Figure 1

Pooled results of the weighted mean difference of age of patients in CTO success groups and CTO failure groups.

Figure 2

Pooled results of the weighted mean difference of lesion length of patients in CTO success groups and CTO failure groups.

Figure 3

Pooled results of the effect of the history of CABG on patients in CTO success groups and CTO failure groups.

Figure 4

Pooled results of the effect of multi-vessel diseases on patients in CTO success groups and CTO failure groups.

Pooled results of the weighted mean difference of age of patients in CTO success groups and CTO failure groups. Pooled results of the weighted mean difference of lesion length of patients in CTO success groups and CTO failure groups. Pooled results of the effect of the history of CABG on patients in CTO success groups and CTO failure groups. Pooled results of the effect of multi-vessel diseases on patients in CTO success groups and CTO failure groups.

The long term effect of PCI on CTO recanalization

A total of 16 articles were studied on long term outcomes (follow up for more than one year) between CTO success group and CTO failure group. Six follow up variables including MACE, MI, all-cause death, angina pectoris, subsequent CABG and accumulative survival rate were analyzed. CTO success rate was associated with significant reduction in MACE (OR, 0.689, 95% CI, 0.488 to 0.971, P = 0.034, Q = 41.951 P < 0.001, I2 = 76.163%, Figure  5), MI (OR, 0.578, 95% CI, 0.387 to 0.864, P = 0.008, Q = 11.80 P = 0.107, I2 = 40.580%, Figure  6), all-cause death (OR, 0.501, 95% CI, 0.384 to 0.654, P < 0.001, Q = 28.283 P = 0.012, I2 = 51.02%, Figure  7), incidence of angina (OR, 0.477, 95%CI, 0.340 to 0.670, P < 0.001, Q = 12.977 P = 0.043, I2 = 53 .764%, Figure  8), subsequent CABG (OR, 0.212, 95% CI, 0.175 to 0.257,P < 0.001, Q = 9.873 P = 0.452, I2 = 0.00%, Figure  9) and cumulative survival rate (hazard ratio (HR), 0.595, 95% CI, 0.488 to 0.791, P < 0.001, Q = 11.714 P = 0.039, I2 = 57.317%, Figure  10).
Figure 5

Pooled results of major adverse cardiac events of patients in CTO success groups and CTO failure groups.

Figure 6

Pooled results of recurrent myocardial infarction of patients in CTO success groups and CTO failure groups.

Figure 7

Pooled results of all-cause death of patients in CTO success groups and CTO failure groups.

Figure 8

Pooled results of recurrent angina of patients in CTO success groups and CTO failure groups.

Figure 9

Pooled results of subsequent CABG of patients in CTO success groups and CTO failure groups.

Figure 10

Pooled results of long-term survival rate of patients in CTO success groups and CTO failure groups.

Pooled results of major adverse cardiac events of patients in CTO success groups and CTO failure groups. Pooled results of recurrent myocardial infarction of patients in CTO success groups and CTO failure groups. Pooled results of all-cause death of patients in CTO success groups and CTO failure groups. Pooled results of recurrent angina of patients in CTO success groups and CTO failure groups. Pooled results of subsequent CABG of patients in CTO success groups and CTO failure groups. Pooled results of long-term survival rate of patients in CTO success groups and CTO failure groups.

Discussion

In this study, a scientific evaluation on the effective of PCI for CTO treatment was carried out. A total of 16 articles involving 6695 cases in successful CTO recanalization (CTO success group) and 2370 cases in failed CTO recanalization (CTO failure group) were included in this research. All the articles were used to identify the factors that influenced the PCI procedure outcome leading to a successful CTO recanalization or failed CTO recanalization. Finally, the clinical baseline characteristics such as age, previous CABG history and lesion baseline characteristics such as lesion length, multi-vessel diseases were considered being the important factors influencing the successful rate of CTO recanalization. Compared to CTO failure patients, the six follow-up variables (MACE, recurrent myocardial infarction, all-cause death, recurrent angina pectoris, subsequent CABG and accumulated survival rate) showed advantage for CTO success patients. A lot of strategies and devices have been developed for a cure of CTO, but the success rate for each treatment is not consistent [33]. Previous study reveals that PCI significantly improved both the local and global function of the left ventricle in CTO patients [34]. Such procedure is beneficial for the symptom in selected patients [35]. However, NCDR (National Cardiovascular Data Registry) suggested that the attempt rate of PCI on CTO have not changed between 2004 and 2009 in the U.S., even though there are significant advance in the techniques in this area [36], indicating that risks under such procedure and factors affecting the success rate existed. Although the use of PCI for CTO increases recently [37], little systematic study directly compared the failed and success surgery cases with successful recanalization to identify the important factors under PCI. In this study, eight clinical baseline characteristics (age, gender, hypertension, hyperlipidemia, diabetes mellitus, smoker, previous myocardial infarction history and CABG history) and the and six lesion baseline characteristics (lesion length, left ventricular ejection fraction, multi-vessel coronary disease, left anterior descending artery lesion, Circumflex artery lesion and right coronary artery disease lesion) were revealed by directly compared the failed and success surgery cases with successful recanalization. The factors such as age, previous CABG history, lesion length and multi-vessel diseases might be important for the successful rate of CTO recanalization. Long-term patency after recanalization of CTO in patients with angina pectoris is associated with improvement in global and regional left ventricular function [38]. BEPM Claessen et al., [39] revealed that the presence of a CTO is associated with long-term mortality. In this study, six follow up variables including MACE, MI, all-cause death, angina pectoris, subsequent CABG and accumulative survival rate were analyzed by meta-analysis. CTO success was found to be associated with significant benefit in all these factors (Table  1), which were consistent with previous studies.
Table 1

Characteristics of 16 included studies

StudyYear of publicationNo. of patientsNo. of patients with successful recanalizationCountryOcclusion time (month)Clinical follow- up (year)
Finci [23]
1990
200
100
Switzerland
3
2
Warren [18]
1990
44
26
Australia
1
2.6
Ivanhoe [19]
1992
480
317
America
3
4
Noguchi [20]
2000
226
134
Japan
3
4.3
Suero [21]
2001
2005
1491
America
1
10
Olivari [22]
2003
376
289
Italy
1
1
Hoye [8]
2005
871
567
Netherland
1
4.5
Drozd [24]
2006
459
298
Poland
1
2.5
Prasad [25]
2007
1262
914
America
3
10
Aziz [26]
2007
543
377
U.K.
3
1.7
Valenti [27]
2008
486
344
Italy
3
1
de Labriolle [28]
2008
172
127
America
3
2
Zhuyanbin [29]
2008
115
81
China
3
3
Chenshaoliang [30]
2009
152
132
China
3
1/3
Yixianhua [31]
2008
1604
157
China
3
3
Liubingwei [32]20084122China32
Characteristics of 16 included studies Although intervention studies that contain only randomized trials as observational studies are not designed for causal inference, observational studies itself also provide information that may suggest important message in certain circumstance [40]. Compared to the patients in CTO success group in our study, patients in CTO failure group were aged with severe lesion length and multi-vessel diseases. These negative effects made their cases more complicated and leaded to complications as well as the end of procedure ahead of time. These factors might be confounding variables for the analysis of the long term effects after PCI procedure. However, the result of clinical baseline characteristics such as age, previous CABG history, lesion length and multi-vessel diseases were not specific. There was no conclusion on how long of lesion length could be benefit for CTO recanalization, or how old of the patients will have higher successful rate of CTO recanalization. Moreover, limitations also existed in this study such as no bias test and text discrepancy. Meanwhile, a subgroup analysis of time effect on the involved studies was necessary.

Conclusions

The factors including age and CABG history as well as the baseline lesion level (lesion length and multi-vessel diseases) might be the important factors influencing the successful rate of CTO recanalization. The in-hospital mortality, MACE, and incidence of subsequent CABG for PCI procedure were significantly lower in the CTO success group compared with those in the CTO failure group. All six follow up variables (MACE, recurrent myocardial infarction, all-cause death, recurrent angina pectoris, subsequent CABG and accumulated survival rate) showed an advantage for CTO patients with a successful recanalization of occlusions.

Abbreviations

CTO: Coronary chronic total occlusion; PCI: Percutaneous coronary intervention; CABG: Coronary artery bypass graft surgery; MACE: Major adverse cardiac events; MI: Myocardial infarction; NCDR: National Cardiovascular Data Registry; PCI: Percutaneous coronary intervention; CI: Confidence interval.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

RL, SY, LT carried out the studies, RL, HC, SG participated and drafted the manuscript. RL, WH, HL carried out the immunoassays. JD, QG, WF participated in the sequence alignment. RL, SG, HL participated in the design of the study and performed the statistical analysis. LT, SY, YY, WF conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
  34 in total

1.  Percutaneous transluminal coronary angioplasty of chronic total occlusions. Determinants of primary success and long-term clinical outcome.

Authors:  T Noguchi; S Miyazaki MD; I Morii; S Daikoku; Y Goto; H Nonogi
Journal:  Catheter Cardiovasc Interv       Date:  2000-03       Impact factor: 2.692

2.  Intravascular ultrasound-guided recanalization of a coronary chronic total occlusion located in a stent implanted subintimally: a case report.

Authors:  Jean-Francois Surmely; Takahiko Suzuki
Journal:  J Cardiol       Date:  2006-08       Impact factor: 3.159

3.  Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles.

Authors:  Ian Shrier; Jean-François Boivin; Russell J Steele; Robert W Platt; Andrea Furlan; Ritsuko Kakuma; James Brophy; Michel Rossignol
Journal:  Am J Epidemiol       Date:  2007-08-21       Impact factor: 4.897

4.  Clinical outcomes of percutaneous coronary intervention for chronic total occlusion lesions in remote hospitals without on-site surgical support.

Authors:  Shao-liang Chen; Fei Ye; Jun-jie Zhang; Song Lin; Zhong-sheng Zhu; Nai-liang Tian; Zhi-zhong Liu; Xue-wen Sun; Ai-ping Zhang; Feng Chen; Shi-qin Ding; Jack Chen
Journal:  Chin Med J (Engl)       Date:  2009-10-05       Impact factor: 2.628

Review 5.  Chronic total occlusion angioplasty in the United States.

Authors:  J Aaron Grantham; Steven P Marso; John Spertus; John House; David R Holmes; Barry D Rutherford
Journal:  JACC Cardiovasc Interv       Date:  2009-06       Impact factor: 11.195

6.  Long-term results of successful and failed angioplasty for chronic total coronary arterial occlusion.

Authors:  L Finci; B Meier; J Favre; A Righetti; W Rutishauser
Journal:  Am J Cardiol       Date:  1990-09-15       Impact factor: 2.778

7.  Late reopening of an occluded infarct related artery improves left ventricular function and long term clinical outcome.

Authors:  F Piscione; G Galasso; G De Luca; G Marrazzo; G Sarno; O Viola; D Accardo; M Chiariello
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

8.  Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention.

Authors:  Bimmer E P M Claessen; René J van der Schaaf; Niels J Verouden; Nienke K Stegenga; Annemarie E Engstrom; Krischan D Sjauw; Wouter J Kikkert; Marije M Vis; Jan Baan; Karel T Koch; Robbert J de Winter; Jan G P Tijssen; Jan J Piek; José P S Henriques
Journal:  JACC Cardiovasc Interv       Date:  2009-11       Impact factor: 11.195

9.  Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions: data from a multicenter, prospective, observational study (TOAST-GISE).

Authors:  Zoran Olivari; Paolo Rubartelli; Federico Piscione; Federica Ettori; Alessandro Fontanelli; Luigi Salemme; Corinna Giachero; Carlo Di Mario; Gabriele Gabrielli; Leonardo Spedicato; Francesco Bedogni
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

10.  Impact of residual chronic total occlusion of right coronary artery on the long-term outcome in patients treated for unprotected left main disease: the Milan and New-Tokyo registry.

Authors:  Kensuke Takagi; Alfonso Ielasi; Alaide Chieffo; Sandeep Basavarajaiah; Azeem Latib; Matteo Montorfano; Mauro Carlino; Hiroyuki Mizuno; Tasuku Hasegawa; Cosmo Godino; Filippo Figini; Joanne Shannon; Ahmed Rezq; Santo Ferrarello; Chiara Bernelli; Toru Naganuma; Yusuke Fujino; Sunao Nakamura; Antonio Colombo
Journal:  Circ Cardiovasc Interv       Date:  2013-04-09       Impact factor: 6.546

View more
  5 in total

1.  The impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcomes.

Authors:  Georgios E Christakopoulos; Muhammad Nauman J Tarar; Emmanouil S Brilakis
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

Review 2.  Myocardial viability in coronary artery chronic total occlusion.

Authors:  Huseng Vefali; Yugandhar Manda; Jamshid Shirani
Journal:  Curr Cardiol Rep       Date:  2015-01       Impact factor: 2.931

3.  Influence of chronic kidney disease on the outcome of patients with chronic total occlusion.

Authors:  Qing-Bin Zhang; Li-Ming Chen; Min Li; Yu-Qi Cui; Chuan-Yan Zhao; Lian-Qun Cui
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

4.  Retraction note: Meta-analysis of the effect of percutaneous coronary intervention on chronic total coronary occlusions.

Authors: 
Journal:  J Cardiothorac Surg       Date:  2015-03-27       Impact factor: 1.637

5.  Impact of chronic total occlusion lesion length on six-month angiographic and 2-year clinical outcomes.

Authors:  Jihun Ahn; Seung-Woon Rha; ByoungGeol Choi; Se Yeon Choi; Jae Kyeong Byun; Ahmed Mashaly; Kareem Abdelshafi; Yoonjee Park; Won Young Jang; Woohyeun Kim; Jah Yeon Choi; EunJin Park; Jin Oh Na; Cheol Ung Choi; EungJu Kim; Chang Gyu Park; Hong Seog Seo; Dong Joo Oh; JinSu Byeon; SangHo Park; HyeYon Yu
Journal:  PLoS One       Date:  2018-11-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.